No Data
No Data
IDEXX Laboratories to Release 2024 Second Quarter Financial Results
IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 second quarter results for Tuesday, August 6, 2024, before the market opens. The Company will
IDEXX Labs Is Maintained at Hold by Stifel
IDEXX Labs Is Maintained at Hold by Stifel
IDEXX Laboratories Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/24/2024 2.88% Stifel $520 → $510 Maintains Hold 05/14/2024 20.23% Morgan Stanley $620 → $596 Maintains
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $510
Stifel analyst Jonathan Block maintains $IDEXX Laboratories Inc(IDXX.US)$ with a hold rating, and adjusts the target price from $520 to $510.According to TipRanks data, the analyst has a success rate
Express News | IDEXX Laboratories Inc : Stifel Cuts Target Price to $510 From $520